Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease
International Journal of Cardiology · 2023
DOI: 10.1016/j.ijcard.2023.03.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiology, 2023. Verfasst von Pascal M Burger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Metabolic Syndrome, Insulin Resistance, Cardiovascular Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: In patients with established cardiovascular disease (CVD), the relation between metabolic syndrome (MetS) and incident heart failure (HF) in the absence of diabetes mellitus (DM) is largely unknown. This study assessed this relation in non-diabetic patients with established CVD. METHODS: Patients from the prospective UCC-SMART cohort with established CVD, but without DM or HF at baseline were included (n = 4653). MetS was defined according to the Adult Treatment Panel III criteria. Insulin resistance was quantified using the homeostasis model of insulin resistance (HOMA-IR). The outcome was a first hospitalization for HF. Relations were assessed using Cox proportional hazards models adjusted for established risk factors: age, sex, prior myocardial infarction (MI), smoking, cholesterol, and kidney function. RESULTS: During a median follow-up of 8.0 years, 290 cases of incident HF were observed (0.81/100 person years). MetS was significantly related to an increased risk of incident HF independent of established risk factors (hazard ratio [HR] 1.32; 95% confidence interval [CI] 1.04-1.68, HR per criterion 1.17; 95% CI 1.06-1.29), as was HOMA-IR (HR per standard deviation [SD] 1.15; 95% CI 1.03-1.29). Of the individual MetS components, only higher waist circumference independently increased the risk of HF (HR per SD 1.34; 95% CI 1.17-1.53). Relations were independent of the occurrence of interim DM and MI, and were not significantly different for HF with reduced vs preserved ejection fraction. CONCLUSION: In CVD patients without a current diagnosis of DM, MetS and insulin resistance increase the risk of incident HF independent of established risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Cardiology, Green Heart Hospital, Gouda, the Netherlands.
- Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Cardiology, Meander Medical Center, Amersfoort, the Netherlands.
Zitieren
APA
Burger, P. M., Koudstaal, S., Dorresteijn, J. A. N., Savarese, G., van der Meer, M. G., de Borst, G. J., Mosterd, A., Visseren, F. L. J., & UCC-SMART study group (2023). Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2023.03.024
Vancouver
Burger PM, Koudstaal S, Dorresteijn JAN, Savarese G, van der Meer MG, de Borst GJ, et al. Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease. International Journal of Cardiology. 2023. doi:10.1016/j.ijcard.2023.03.024
BibTeX
@article{Burger2023,
author = {Burger, Pascal M and Koudstaal, Stefan and Dorresteijn, Jannick A N and Savarese, Gianluigi and van der Meer, Manon G and de Borst, Gert J and Mosterd, Arend and Visseren, Frank L J and UCC-SMART study group, UCC-SMART study group},
title = {Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease},
journal = {International Journal of Cardiology},
year = {2023},
doi = {10.1016/j.ijcard.2023.03.024}
}
EUVIMED